Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Treasury Shares (2016 - 2024)

Historic Treasury Shares for Innoviva (INVA) over the last 9 years, with Q1 2024 value amounting to $393.8 million.

  • Innoviva's Treasury Shares changed 0.0% to $393.8 million in Q1 2024 from the same period last year, while for Mar 2024 it was $393.8 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $393.8 million for FY2023, which is 0.0% changed from last year.
  • As of Q1 2024, Innoviva's Treasury Shares stood at $32.0 million, which was down 0.0% from $32.0 million recorded in Q4 2023.
  • Over the past 5 years, Innoviva's Treasury Shares peaked at $32.0 million during Q2 2021, and registered a low of -$32.0 million during Q4 2021.
  • For the 4-year period, Innoviva's Treasury Shares averaged around $21.5 million, with its median value being $32.0 million (2021).
  • Over the last 5 years, Innoviva's Treasury Shares had its largest YoY gain of 0.0% in 2022, and its largest YoY loss of 0.0% in 2022.
  • Over the past 4 years, Innoviva's Treasury Shares (Quarter) stood at $393.8 million in 2021, then changed by 0.0% to $393.8 million in 2022, then changed by 0.0% to $393.8 million in 2023, then changed by 0.0% to $393.8 million in 2024.
  • Its Treasury Shares stands at $393.8 million for Q1 2024, versus $393.8 million for Q4 2023 and $393.8 million for Q3 2023.